Weed.de does not just report sales. We report price integrity.
The Margin Index is a nine-metric monthly intelligence pack for manufacturer partners. Built on the live Weed.de pharmacy-order ledger covering 95 manufacturers, 264 pharmacy partners, and €12,6 M of dispensed cannabis sales — translated into the brand-economics metrics that actually move your P&L.
Marketplace metrics — orders, revenue, units — describe what the channel did. Brand-economics metrics describe what your brand did inside that channel. The Margin Index is the second kind.
What's in the monthly pack — and what we read from it.
Avg grams per Weed.de patient
Shows basket depth. Reveals whether patients are filling full prescriptions or splitting orders across channels.
Avg €/g achieved
Shows price discipline. The single hardest number to fake — it falls the moment you start discounting.
Repeat order rate
Shows patient retention. Tells you whether your SKU earned a second prescription, or only a first.
Product mix by price tier
Shows whether your premium SKUs are holding. Trade-down to the value tier is the earliest signal of price erosion.
Substitution loss
Shows when patients switch away due to price or availability — and which competitor caught them.
Education-assisted conversion
Shows whether Weed.de content actually moved patients to your SKU — search query → page view → prescription.
Pharmacy availability coverage
Shows whether out-of-stock is killing premium demand. Coverage gaps cost more than discounting.
Competitor price pressure alerts
Shows when a comparable SKU drops in price — before patients notice and substitute.
Margin-preserved revenue estimate
Shows the incremental euro value Weed.de delivered above the cheap-channel baseline. The number that pays for the report.
Three layers — order ledger, content telemetry, modeled fit.
Live order ledger
Every order written across 264 pharmacy partners — manufacturer, SKU, grams, price, pharmacy — into a single ledger. Daily refresh.
Content telemetry
Search queries, education page views, and SKU detail-page sessions joined to the order ledger via patient ID. Reveals which Weed.de content earned the prescription.
Modeled fit index
For each manufacturer: substitution risk, pharmacy coverage gaps, and competitor pressure scored against the partner's own SKU portfolio. Outputs three-action priorities each month.
A one-page Price Integrity Report — every month — per brand.
- Headline price-integrity score (+/− vs marketplace baseline)
- Margin-preserved revenue estimate, in €
- Demand-quality block: grams / patient, repeat rate, premium-tier basket share
- Top SKU education-impact table
- Pharmacy coverage gap + top 3 placement targets
- Three content pieces, three pharmacy targets, two SKUs to protect, one to push
- Direct line to the Weed.de partnerships team
The Margin Index works at the manufacturer end. Brand integrity at fulfillment is protected by the pharmacy-facing toolkit.
See the pharmacy toolkit →Subscription tiers
For emerging brands establishing their first market presence.
- Quarterly automated report
- Metrics 1–3 included
- Public marketplace baselines
- Email support
For active commercial partners managing multiple SKUs.
- Monthly Price Integrity Report
- All nine metrics included
- Three-action priorities
- Direct partnership lead
For top-15 manufacturers by volume requiring deep data access.
- Monthly report + raw data export
- Dedicated analyst hour
- Custom KPI build
- Quarterly C-suite review